title: RE: Denosumab for patients with persistent or relapsed hypercalcemia of malignancy despite recent bisphosphonate treatment.
authors: Academic Oncology Department, Nottingham City Hospital, Nottingham, UK (JA, YN, SS). jadhikaree@doctors.org.uk.
authors: Jason
authors: J
authors: Adhikaree
authors: Academic Oncology Department, Nottingham City Hospital, Nottingham, UK (JA, YN, SS).
authors: Yvette
authors: Y
authors: Newby
authors: Academic Oncology Department, Nottingham City Hospital, Nottingham, UK (JA, YN, SS).
authors: Santhanam
authors: S
authors: Sundar
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D050071:Bone Density Conservation Agents / Q000627:therapeutic use*; D001859:Bone Neoplasms / Q000150:complications*; D004164:Diphosphonates / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D006934:Hypercalcemia / Q000188:drug therapy* / Q000209:etiology*; D008297:Male
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D050071:Bone Density Conservation Agents; D004164:Diphosphonates